• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Documentation of Dementia as a Cause of Death Among Mexican-American Decedents Diagnosed with Dementia.记录墨西哥裔美国人死者中因痴呆而死亡的情况。
J Alzheimers Dis. 2021;82(4):1727-1736. doi: 10.3233/JAD-210361.
2
End-of-Life Healthcare Utilization of Older Mexican Americans With and Without a Diagnosis of Alzheimer's Disease and Related Dementias.老年墨西哥裔美国人在诊断患有阿尔茨海默病及相关痴呆症和未诊断患有阿尔茨海默病及相关痴呆症的情况下的临终医疗保健利用情况。
J Gerontol A Biol Sci Med Sci. 2020 Jan 20;75(2):326-332. doi: 10.1093/gerona/glz065.
3
Healthcare utilization of Mexican-American Medicare beneficiaries with and without Alzheimer's disease and related dementias.墨西哥裔美国医疗保险受益人与阿尔茨海默病和相关痴呆症患者与非患者的医疗保健利用情况。
PLoS One. 2020 Jan 15;15(1):e0227681. doi: 10.1371/journal.pone.0227681. eCollection 2020.
4
Changes in Health Care Use by Mexican American Medicare Beneficiaries Before and After a Diagnosis of Dementia.墨西哥裔美国医疗保险受益人的医疗保健使用变化在痴呆症诊断前后。
J Gerontol A Biol Sci Med Sci. 2021 Feb 25;76(3):534-542. doi: 10.1093/gerona/glaa236.
5
Racial and Ethnic Differences in Hospice Use and Hospitalizations at End-of-Life Among Medicare Beneficiaries With Dementia.在患有痴呆症的 Medicare 受益人群中,临终关怀使用和住院治疗的种族和民族差异。
JAMA Netw Open. 2022 Jun 1;5(6):e2216260. doi: 10.1001/jamanetworkopen.2022.16260.
6
Trends in US Medicare Decedents' Diagnosis of Dementia From 2004 to 2017.2004 年至 2017 年美国医疗保险死亡者的痴呆症诊断趋势。
JAMA Health Forum. 2022 Apr 1;3(4):e220346. doi: 10.1001/jamahealthforum.2022.0346. eCollection 2022 Apr.
7
Healthcare Utilization and Mortality After Hospice Live Discharge Among Medicare Patients With and Without Alzheimer's Disease and Related Dementias.医疗保险患者在临终关怀出院后接受医疗服务的利用情况和死亡率,以及阿尔茨海默病和相关痴呆症患者和非阿尔茨海默病和相关痴呆症患者的比较。
J Gen Intern Med. 2023 Aug;38(10):2272-2278. doi: 10.1007/s11606-023-08031-8. Epub 2023 Jan 17.
8
Dementia and Medicare at life's end.生命末期的痴呆症与医疗保险
Health Serv Res. 2008 Apr;43(2):714-32. doi: 10.1111/j.1475-6773.2007.00787.x.
9
Evaluation of Federal Policy Changes to the Hospice Benefit and Use of Hospice for Persons With ADRD.评估联邦政策对临终关怀福利的改变以及痴呆症患者使用临终关怀的情况。
JAMA Health Forum. 2022 May 6;3(5):e220900. doi: 10.1001/jamahealthforum.2022.0900. eCollection 2022 May.
10
Emergency and post-emergency care of older adults with Alzheimer's disease/Alzheimer's disease related dementias.老年人阿尔茨海默病/阿尔茨海默病相关痴呆的紧急和灾后护理。
J Am Geriatr Soc. 2022 Sep;70(9):2582-2591. doi: 10.1111/jgs.17833. Epub 2022 May 25.

引用本文的文献

1
"What Matters" to Community-Dwelling Older Adults With Dementia and Their Family Caregivers: A Qualitative Pilot Study.对患有痴呆症的社区居家老年人及其家庭照顾者而言“重要之事”:一项定性先导研究
Sage Open Aging. 2025 Jul 23;11:30495334251358620. doi: 10.1177/30495334251358620. eCollection 2025 Jan-Dec.
2
Annual Wellness Visits and Early Dementia Diagnosis Among Medicare Beneficiaries.医疗保险受益人的年度健康访视和早期痴呆诊断。
JAMA Netw Open. 2024 Oct 1;7(10):e2437247. doi: 10.1001/jamanetworkopen.2024.37247.
3
Accuracy of death certifications of diabetes, dementia and cancer in Australia: a population-based cohort study.澳大利亚糖尿病、痴呆和癌症死亡证明的准确性:一项基于人群的队列研究。
BMC Public Health. 2022 May 6;22(1):902. doi: 10.1186/s12889-022-13304-8.

本文引用的文献

1
Assessment of Racial/Ethnic Disparities in Timeliness and Comprehensiveness of Dementia Diagnosis in California.加利福尼亚州痴呆症诊断及时性和全面性的种族/民族差异评估。
JAMA Neurol. 2021 Jun 1;78(6):657-665. doi: 10.1001/jamaneurol.2021.0399.
2
Awareness of Palliative Care, Hospice Care, and Advance Directives in a Racially and Ethnically Diverse Sample of California Adults.加利福尼亚州成年人群体中对姑息治疗、临终关怀和预先指示的认知:一项种族和民族多样化的研究
Am J Hosp Palliat Care. 2021 Jun;38(6):601-609. doi: 10.1177/1049909121991522. Epub 2021 Feb 4.
3
National Trends in Hospice Facility Deaths in the United States, 2003-2017.美国 2003-2017 年的临终关怀机构死亡人数的全国趋势。
J Pain Symptom Manage. 2021 Feb;61(2):350-357. doi: 10.1016/j.jpainsymman.2020.08.026. Epub 2020 Aug 25.
4
Estimates of the Association of Dementia With US Mortality Levels Using Linked Survey and Mortality Records.利用关联调查和死亡率记录估计痴呆症与美国死亡率水平的关系。
JAMA Neurol. 2020 Dec 1;77(12):1543-1550. doi: 10.1001/jamaneurol.2020.2831.
5
Cause of death in autopsy-confirmed dementia disorders.尸检确诊痴呆障碍的死因。
Eur J Neurol. 2020 Dec;27(12):2415-2421. doi: 10.1111/ene.14450. Epub 2020 Aug 31.
6
Deaths: Final Data for 2017.死亡:2017年最终数据。
Natl Vital Stat Rep. 2019 Jun;68(9):1-77.
7
Healthcare utilization of Mexican-American Medicare beneficiaries with and without Alzheimer's disease and related dementias.墨西哥裔美国医疗保险受益人与阿尔茨海默病和相关痴呆症患者与非患者的医疗保健利用情况。
PLoS One. 2020 Jan 15;15(1):e0227681. doi: 10.1371/journal.pone.0227681. eCollection 2020.
8
Death Certification: Errors and Interventions.死亡证明:错误与干预措施
Clin Med Res. 2020 Mar;18(1):21-26. doi: 10.3121/cmr.2019.1496. Epub 2019 Oct 9.
9
Longitudinal analysis of dementia diagnosis and specialty care among racially diverse Medicare beneficiaries.种族多样化的 Medicare 受益人群中痴呆症诊断和专业护理的纵向分析。
Alzheimers Dement. 2019 Nov;15(11):1402-1411. doi: 10.1016/j.jalz.2019.07.005. Epub 2019 Sep 4.
10
Differences in hospitalizations, emergency room admissions, and outpatient visits among Mexican-American Medicare beneficiaries.墨西哥裔美国医疗保险受益人的住院、急诊室就诊和门诊就诊差异。
BMC Geriatr. 2019 May 21;19(1):136. doi: 10.1186/s12877-019-1160-9.

记录墨西哥裔美国人死者中因痴呆而死亡的情况。

Documentation of Dementia as a Cause of Death Among Mexican-American Decedents Diagnosed with Dementia.

机构信息

Division of Rehabilitation Sciences, School of Health Professions, University of Texas Medical Branch, Galveston, TX, USA.

Sealy Center on Aging, University of Texas Medical Branch, Galveston, TX, USA.

出版信息

J Alzheimers Dis. 2021;82(4):1727-1736. doi: 10.3233/JAD-210361.

DOI:10.3233/JAD-210361
PMID:34219726
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8384698/
Abstract

BACKGROUND

Hispanic older adults are a high-risk population for Alzheimer's disease and related dementias (ADRD) but are less likely than non-Hispanic White older adults to have ADRD documented as a cause of death on a death certificate.

OBJECTIVE

To investigate characteristics associated with ADRD as a cause of death among Mexican-American decedents diagnosed with ADRD.

METHODS

Data came from the Hispanic Established Populations for the Epidemiologic Study of the Elderly, Medicare claims, and National Death Index.

RESULTS

The final sample included 853 decedents diagnosed with ADRD of which 242 had ADRD documented as a cause of death. More health comorbidities (OR = 0.40, 95% CI = 0.28-0.58), older age at death (OR = 1.18, 95% CI = 1.03-1.36), and longer ADRD duration (OR = 1.08, 95% CI = 1.03-1.14) were associated with ADRD as a cause of death. In the last year of life, any ER admission without a hospitalization (OR = 0.45, 95% CI = 0.22-0.92), more physician visits (OR = 0.96, 95% CI = 0.93-0.98), and seeing a medical specialist (OR = 0.46, 95% CI = 0.29-0.75) were associated with lower odds for ADRD as a cause of death. In the last 30 days of life, any hospitalization with an ICU stay (OR = 0.55, 95% CI = 0.36-0.82) and ER admission with a hospitalization (OR = 0.67, 95% CI = 0.48-0.94) were associated with lower odds for ADRD as a cause of death. Receiving hospice care in the last 30 days of life was associated with 1.98 (95% CI = 1.37-2.87) higher odds for ADRD as a cause of death.

CONCLUSION

Under-documentation of ADRD as a cause of death may reflect an underestimation of resource needs for Mexican-Americans with ADRD.

摘要

背景

西班牙裔老年人是阿尔茨海默病和相关痴呆症(ADRD)的高危人群,但与非西班牙裔白人老年人相比,ADRD 作为死亡证明上的死因的记录较少。

目的

调查与墨西哥裔美国死者 ADRD 死因相关的特征,这些死者被诊断患有 ADRD。

方法

数据来自西班牙裔老年人的既定人群流行病学研究、医疗保险索赔和国家死亡指数。

结果

最终样本包括 853 名被诊断患有 ADRD 的死者,其中 242 名 ADRD 被记录为死因。更多的健康合并症(OR=0.40,95%CI=0.28-0.58)、死亡时年龄较大(OR=1.18,95%CI=1.03-1.36)和更长的 ADRD 持续时间(OR=1.08,95%CI=1.03-1.14)与 ADRD 作为死因相关。在生命的最后一年,任何无住院的急诊入院(OR=0.45,95%CI=0.22-0.92)、更多的医生就诊(OR=0.96,95%CI=0.93-0.98)和看专科医生(OR=0.46,95%CI=0.29-0.75)与 ADRD 作为死因的可能性降低相关。在生命的最后 30 天,任何 ICU 住院的住院治疗(OR=0.55,95%CI=0.36-0.82)和急诊入院伴住院治疗(OR=0.67,95%CI=0.48-0.94)与 ADRD 作为死因的可能性降低相关。在生命的最后 30 天接受临终关怀与 ADRD 作为死因的可能性增加 1.98 倍(95%CI=1.37-2.87)相关。

结论

ADRD 作为死因的记录不足可能反映了对患有 ADRD 的墨西哥裔美国人资源需求的低估。